Lyra Therapeutics, Inc.LYRANASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank33
Year-over-Year Change
Year-over-year earnings per share growth rate
Percentile
P33
Within normal range
vs 2Y Ago
-0.3x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -13.49% |
| 2023 | 31.15% |
| 2022 | 45.37% |
| 2021 | -29.34% |
| 2020 | 95.86% |
| 2019 | -6277.55% |
| 2018 | 0.00% |